NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR RELEASE TO US NEWS WIRE SERVICES

Pacific-Link Capital Inc. (TSX VENTURE:PCL.H) ("Pacific-Link") is pleased to
announce that it has entered into an arm's length non-binding letter of intent
(the "LOI") dated November 22, 2012 with Eidam Diagnostics Corporation
("Eidam"), whereby Pacific-Link will acquire all of the issued and outstanding
securities in the capital of Eidam in exchange for the issuance of the common
shares of Pacific-Link (the "Proposed Transaction").


It is anticipated that the Proposed Transaction will take the form of an
amalgamation or such other form of business combination to be determined by the
parties, subject to approval by the TSXV Venture Exchange (the "Exchange") and,
if accepted, is intended to be Pacific-Link's "Qualifying Transaction" as that
term is defined in Exchange Policy 2.4 Capital Pool Companies ("Policy 2.4").


Under the terms of the Proposed Transaction, the common shares of Pacific-Link
will be consolidated on a 2 for 1 basis resulting in 3,265,000 common shares at
$0.20 per common share immediately prior to closing of the Proposed Transaction.
Eidam shareholders will receive one post-consolidated common share of
Pacific-Link for each Eidam share held.


As a condition to the Proposed Transaction, Eidam is required to raise a minimum
of $750,000 to a maximum of $1,000,000 in new funding (the "Eidam Financing"),
the terms of which will be disclosed in a subsequent news release. The
definitive agreement in respect of the Proposed Transaction is expected to be
entered into following completion of a valuation report by Eidam and the review
by Pacific-Link of such valuation report along with Eidam's financials.


About Eidam

Eidam Diagnostics Corporation is a privately held Canadian company headquartered
in Richmond, British Columbia. Eidam's primary product is the CRT 2000(TM)
Thermographic System (the "Product"), which is a non-invasive, radiation-free,
reproducible thermographic tool that measures the temperature of pre-determined
skin points and analyzes such data to provide a healthcare practitioner with
information that may be indicative of irregular body function. The Product has
obtained the CE Mark, is available for sale in the United States based upon its
FDA premarket notification (510(k)) and is also certified as a Class II medical
device by the Chinese health authority. The Product was developed based on the
intellectual property acquired from Capital 21 Holdings Corporation, a related
corporate entity to Eidam.


Details of the Proposed Transaction

It is expected that on closing of the Qualifying Transaction, the Resulting
Issuer as that term is defined in Policy 2.4 will be a Tier 2 Technology Issuer
on the Exchange, engaged in the business operations of marketing and selling of
the Product. As the Proposed Transaction will not be a "Non- Arm's Length
Qualifying Transaction" as that term is defined in Policy 2.4., Pacific-Link
does not expect that the Proposed Transaction will require the approval of its
shareholders.


Conditions to Completion of the Proposed Transaction

Closing of the Proposed Transaction is subject to satisfaction or waiver of
terms and conditions, customary or otherwise, including but not limited to,
acceptance by the Exchange of the Proposed Transaction, requisite shareholder
approval where applicable and any other applicable approvals. There can be no
assurance that the Proposed Transaction will be completed as proposed or at all.


Closing of the Proposed Transaction is also conditional on Eidam completing the
Eidam Financing in conjunction therewith or immediately prior thereto. The
proceeds from the Eidam Financing will be used for business operations of the
Resulting Issuer, costs to complete the Proposed Transaction and for unallocated
working capital. There may be circumstances where, for sound business reasons, a
reallocation of funds may be necessary in order for the Resulting Issuer to
achieve its business objectives.


Pacific-Link and Eidam will provide further disclosure, including milestones,
details regarding the Management Team (as defined below) and the Eidam Financing
terms, by way of news release as such information becomes available.


All information contained in this news release with respect to Pacific-Link and
Eidam was supplied by the parties respectively, for inclusion herein, and
Pacific-Link and its directors and officers have relied on Eidam for any
information concerning Eidam.


Management and Board of Directors

Upon completion of the Proposed Transaction, it is anticipated that Pacific-Link
together with Eidam will nominate and appoint the directors and senior
management (the "Management Team") of the Resulting Issuer.


Sponsorship of Qualifying Transaction

Pacific-Link intends to seek an exemption from the sponsorship requirement of
the Exchange, but will appoint one if required to do so.


Trading Halted

In accordance with the policies of the Exchange, Pacific-Link's common shares
are currently halted from trading and will remain so until such time as the
Exchange determines otherwise, which, depending on the policies of the Exchange,
may not occur until the completion of the Proposed Transaction.


Finder's Fee

A finder's fee in connection with the Proposed Transaction will be paid as
permitted by and subject to approval by the Exchange.


About Pacific-Link

Pacific-Link is a capital pool company as that term is defined in Policy 2.4 and
is in the business of identifying and evaluating businesses and assets with a
view to completing a Qualifying Transaction. Pacific-Link is listed on the NEX
board of the Exchange under the trading symbol PCL.H.


On behalf of the board of PACIFIC-LINK CAPITAL INC.

Patrick Wong, President, Chief Executive Officer and Director

COMPLETION OF THE TRANSACTION IS SUBJECT TO A NUMBER OF CONDITIONS, INCLUDING
BUT NOT LIMITED TO, EXCHANGE ACCEPTANCE AND IF APPLICABLE PURSUANT TO EXCHANGE
REQUIREMENTS, MAJORITY OF THE MINORITY SHAREHOLDER APPROVAL. WHERE APPLICABLE,
THE TRANSACTION CANNOT CLOSE UNTIL THE REQUIRED SHAREHOLDER APPROVAL IS
OBTAINED. THERE CAN BE NO ASSURANCE THAT THE TRANSACTION WILL BE COMPLETED AS
PROPOSED OR AT ALL.


INVESTORS ARE CAUTIONED THAT, EXCEPT AS DISCLOSED IN THE MANAGEMENT INFORMATION
CIRCULAR OR FILING STATEMENT TO BE PREPARED IN CONNECTION WITH THE TRANSACTION,
ANY INFORMATION RELEASED OR RECEIVED WITH RESPECT TO THE TRANSACTION MAY NOT BE
ACCURATE OR COMPLETE AND SHOULD NOT BE RELIED UPON. TRADING IN THE SECURITIES OF
A CAPITAL POOL COMPANY SHOULD BE CONSIDERED HIGHLY SPECULATIVE.


Forward-Looking Statements: This news release includes certain forward-looking
information and forward-looking statements (collectively "Forward-Looking
Statements") concerning the future performance of the Pacific-Link's business,
operations and financial performance and condition, as well as management's
objectives, strategies, beliefs and intentions. Forward-Looking Statements are
frequently identified by such words as "may", "will", "plan", "expect",
"anticipate", "estimate", "intend" and similar words referring to future events
and results. Forward-Looking Statements are based on the current opinions and
expectations of management. All Forward-Looking Statements are inherently
uncertain and subject to a variety of risks and uncertainties, including the
speculative nature of mineral exploration and development generally and
specifically in respect of the interpretation of the geology, continuity, grade
and size of mineral deposits, unanticipated operational or technical
difficulties, fluctuating commodity prices, competitive risks and the
availability of financing, changes in laws or regulations, changes in the
financial markets and changes in general economic conditions, as described in
more detail in our recent securities filings available at www.sedar.com. Such
Forward-Looking Statements are based on a number of assumptions, including but
not limited to the level and volatility of the price of molybdenum, the
availability of financing, the accuracy of reserve and resource estimates and
the assumptions on which those estimates are based and the ability to achieve
and maintain certain operational efficiencies. Should one or more risks and
uncertainties materialize or should any assumptions prove incorrect, then actual
events or results may differ materially from those expressed or implied in the
Forward Looking-Statements and we caution against placing undue reliance
thereon. We assume no obligation to revise or update these Forward-Looking
Statements, except as required by applicable law.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Pacific-Link Capital Inc.
Patrick Wong
President, Chief Executive Officer and Director
(604) 739-9500
(604) 739-9394 (FAX)
patrick@wongrobinson.com

(TSXV:PCL.H)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more  Charts.
(TSXV:PCL.H)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more  Charts.